Structural and aesthetic peptide protocols — GHK-Cu, glutathione, collagen-support peptides. Dose ranges, delivery routes, cycles, and reconstitution.
This group covers structural and aesthetic applications. GHK-Cu is a copper-binding tripeptide studied for collagen synthesis, skin remodelling, and hair follicle activity, delivered topically or subcutaneously. Glutathione is studied as an antioxidant with downstream effects on skin tone and oxidative stress.
Category overview
Support skeletal strength, joint mobility, and skin integrity with FDA-approved and bioactive options.
Protocols at a glance
Peptide
Dose range
Frequency
Cycle
Teriparatide
20 – 80 mcg
Daily SubQ
18–24 months maximum (FDA limit); then switch to bisphosphonates
Collagen Peptides
5 – 20 g
Daily oral
Continuous use acceptable; no cycling needed
Teriparatide — Forteo
FDA-approved PTH analog for osteoporosis. The only bone-building (anabolic) treatment available. Prescription-only for serious bone density issues.
Dose range: 20 – 80 mcg. Frequency: Daily SubQ. Cycle: 18–24 months maximum (FDA limit); then switch to bisphosphonates.
Reconstitution: Pre-filled pen device — refer to manufacturer
Increases bone formation (20%+ density gain possible)
FDA-approved for osteoporosis treatment
Heals vertebral fractures faster
Reduces fracture risk significantly
Risk of hypercalcemia at higher doses.
Stacks: MK-677, BPC-157, Calcium + Vitamin D
Collagen Peptides — Hydrolyzed
Oral bioactive peptides derived from collagen. Support skin, joint, bone, and gut health. Widely available as supplements with good safety profile.
Dose range: 5 – 20 g. Frequency: Daily oral. Cycle: Continuous use acceptable; no cycling needed.
Reconstitution: Oral powder — mix with liquid of choice
Supports skin elasticity and hydration
Reduces joint pain and improves mobility
Supports bone density maintenance
Gut lining support
Takes 8–12 weeks to see benefits.
Stacks: Vitamin C (collagen synthesis co-factor), GHK-Cu (topical), Hyaluronic acid
Safety principles
Start Low, Go Slow: Always begin with the minimum effective dose and titrate gradually over weeks.
Get Baseline Bloodwork: Before starting, obtain labs including CBC, CMP, lipid panel, hormone panel (testosterone, estrogen, IGF-1, GH), fasting insulin, HbA1c, liver enzymes, and inflammatory markers.
Monitor Regularly: Retest labs every 4–8 weeks. Track subjective markers daily (sleep, energy, mood, appetite, injection site reactions).
Source Responsibly: Only use peptides from reputable compounding vendors with third-party COA testing. We STRONGLY recommend they also are based out of the USA for quality assurance.
Recognize Warning Signs: Stop immediately and seek medical attention for severe injection site reactions, difficulty breathing, chest pain, severe headache, vision changes, or allergic reactions.
Drug Interactions: Many peptides interact with insulin, diabetes drugs, blood thinners, immunosuppressants, and hormonal therapies.
Contraindications: Not for pregnant/breastfeeding women, individuals under 18, those with active cancer, severe liver/kidney disease, or uncontrolled diabetes.
Important
All peptide products referenced are intended solely for research, investigational, or licensed professional use. They are not FDA-approved and are not intended to diagnose, treat, cure, or prevent any disease. Consult a licensed medical practitioner before any personal or clinical use.